Source:http://linkedlifedata.com/resource/pubmed/id/15631942
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2005-1-5
|
pubmed:abstractText |
l-Arginine is substrate for nitric oxide (NO) synthesis and produces pulmonary vasodilatory effects in patients with pulmonary hypertension and in hypoxic animals. We hypothesized that l-arginine would attenuate the increase in oxidative stress and the pulmonary hypertension observed during acute pulmonary embolism (APE). Using an isolated lung perfusion rat model of APE, we examined whether l-arginine (0, 0.1, 0.5, 3, and 10 mmol/L) attenuates the pulmonary hypertension induced by the injection of 6.6 mg/kg of 300 microm Sephadex microspheres into the pulmonary artery. Thiobarbituric acid reactive species (TBA-RS) and nitrite/nitrate (NO(x)) concentrations were measured in lung perfusate to assess oxidative stress and NO production. l-Arginine (0.5, 3, and 10 mmol/L) attenuated (all P<0.05) APE-induced pulmonary hypertension by about 50%. The protective effect of l-arginine was completely reversed by inhibition of NO synthesis with l-NAME (4 mmol/L). In addition, l-arginine (0.5-10 mmol/L) blunted the increase in TBA-RS observed after APE. NO(x) tended to increase only when l-arginine (10 mmol/L) was added to the lung perfusate of non-embolized lungs. Taken together, these findings suggest that l-arginine attenuates APE-induced pulmonary hypertension through antioxidant mechanisms involving increased NO synthesis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Arginine,
http://linkedlifedata.com/resource/pubmed/chemical/Dextrans,
http://linkedlifedata.com/resource/pubmed/chemical/NG-Nitroarginine Methyl Ester,
http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide,
http://linkedlifedata.com/resource/pubmed/chemical/Thiobarbituric Acid Reactive...,
http://linkedlifedata.com/resource/pubmed/chemical/sephadex
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1089-8603
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
12
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
9-14
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15631942-Acute Disease,
pubmed-meshheading:15631942-Animals,
pubmed-meshheading:15631942-Arginine,
pubmed-meshheading:15631942-Dextrans,
pubmed-meshheading:15631942-Disease Models, Animal,
pubmed-meshheading:15631942-Dose-Response Relationship, Drug,
pubmed-meshheading:15631942-Hypertension, Pulmonary,
pubmed-meshheading:15631942-Male,
pubmed-meshheading:15631942-NG-Nitroarginine Methyl Ester,
pubmed-meshheading:15631942-Nitric Oxide,
pubmed-meshheading:15631942-Oxidative Stress,
pubmed-meshheading:15631942-Pulmonary Artery,
pubmed-meshheading:15631942-Pulmonary Embolism,
pubmed-meshheading:15631942-Rats,
pubmed-meshheading:15631942-Rats, Wistar,
pubmed-meshheading:15631942-Thiobarbituric Acid Reactive Substances
|
pubmed:year |
2005
|
pubmed:articleTitle |
l-Arginine attenuates acute pulmonary embolism-induced oxidative stress and pulmonary hypertension.
|
pubmed:affiliation |
Department of Pharmacology, Faculty of Medicine of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, Brazil.
|
pubmed:publicationType |
Journal Article,
In Vitro,
Research Support, Non-U.S. Gov't
|